SCHEMBL1807796

SCHEMBL1807796

COCc1n[nH]c(-c2ccccc2F)c1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK4 O00444 1/20 0.40
PDPK1 O15530 1/20 0.40
DAPK3 O43293 1/20 0.40
DYRK3 O43781 1/20 0.40
PRKD3 O94806 1/20 0.40
MAP4K4 O95819 1/20 0.40
CHEK2 O96017 1/20 0.40
CDK1 P06493 1/20 0.40
FES P07332 1/20 0.40
RET P07949 1/20 0.40
PIM1 P11309 1/20 0.40
FGFR1 P11362 1/20 0.40
FER P16591 1/20 0.40
CDK2 P24941 1/20 0.40
MARK3 P27448 1/20 0.40
MAPK1 P28482 1/20 0.40
FLT4 P35916 1/20 0.40
KDR P35968 1/20 0.40
FLT3 P36888 1/20 0.40
MAPK9 P45984 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1806119 0.79 ALDH1A1 (0.39) PLK4PDPK1DAPK3DYRK3PRKD3
SCHEMBL1807315 0.78 ALDH1A1 (0.38) PLK4PDPK1DAPK3DYRK3PRKD3
SCHEMBL1805611 0.72 PLK4 (0.38) PLK4PDPK1DAPK3DYRK3PRKD3
SCHEMBL12464576 0.70 HCAR2 (0.45) KDRCSNK2A1HCAR2ALDH1A1LMNA
SCHEMBL4947186 0.69 GPBAR1 (0.43) CYP3A4CYP2C9CYP2C19DHODHDHFR
SCHEMBL1807759 0.69 TDP2 (0.42) ALDH1A1HSD17B10SMN1; SMN2IDO1ALOX5
SCHEMBL25240918 0.68 HCAR2 (0.44) MAPK1HCAR2ALDH1A1
SCHEMBL6230832 0.68 PTGER1 (0.44) CDK1CDK2ALDH1A1SMN1; SMN2
SCHEMBL1804834 0.67 PLK4 (0.40) PLK4PDPK1DAPK3DYRK3PRKD3
SCHEMBL6844767 0.64 LMNA (0.43) PLK4PDPK1DAPK3DYRK3PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501704-A1 SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS Eli Lilly and Company (US) 2012-09-26 EP disclosed
WO-2011060217-A1 SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2011-05-19 WO disclosed